Akèy › Ensifizyans kadyak › Washington
Etid klinik pou Ensifizyans kadyak nan Washington
26 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan Washington.
Vil nan Washington
Tèks ofisyèl etid la (Anglè)
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Redmond
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Providence Advanced Heart Disease and Transplant, Spokane
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06736574A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Virginia Mason Medical Center, Seattle
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06424288Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Pulse Heart Institute, Puyallup
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Spokane, WA Investigative Site 10123, Spokane
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 132, Seattle
Ap rekriteFaz 2
Laj 30 a 84 · Tout sèks · Mizajou Aug 31, 2026 · NCT07795814Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Seattle Children's Hospital-Cardiology/Fetal Therapy ( Site 0019), Seattle
Ap rekriteFaz 2/3
29 Days – 17 Years · Tout sèks · Mizajou Aug 28, 2026 · NCT05714085AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Swedish Heart & Vascular Institute, Advanced Cardiac Support Program, Seattle
Ap rekriteFaz 2
Laj 40 a 85 · Tout sèks · Mizajou Aug 27, 2026 · NCT06793371Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Olympia
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 20, 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Virginia Mason Medical Center, Seattle
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Seattle
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Aug 19, 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Swedish Medical Center_Seattle, Seattle
- CHI Franciscan Research Center, Tacoma
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Seattle Children's Hospital, Seattle
Ap rekriteFaz 2
Laj 0 a 16 · Tout sèks · Mizajou Aug 10, 2026 · NCT06080074Assessment of CCM in HF With Higher Ejection Fraction
- Swedish Medical Center, Seattle
- Peace Health, Vancouver
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05064709ELEVATE-HFpEF Clinical Study
- Saint Joseph Medical Center (Tacoma WA), Tacoma
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT06678841PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Providence Everett, Everett
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487Repurposing Valsartan May Protect Against Pulmonary Hypertension
- University of Washington Medical Center, Seattle
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou May 4, 2026 · NCT06053580CCM OPEN HF Registry
- PeaceHealth Southwest Medical Center, Vancouver
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07112924Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06217302XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- University of Washington Medical Center, Seattle
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT06895070Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
- University of Washington, Seattle
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT07105007Left vs Left Randomized Clinical Trial
- University of Washington, Seattle
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05650658Cardiogenic Shock Working Group Registry
- University of Washington Medical Center, Seattle
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 6, 2025 · NCT04682483Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
- University of Washington Medicine, Seattle
Ap rekriteFaz 1/2
Laj 18 a 80 · Tout sèks · Mizajou Mar 26, 2024 · NCT04703842Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
- University of Washington Medical Center, Seattle
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 23, 2021 · NCT02537769Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.